AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 1-25/75
ADMINISTRATION OF ABCIXIMAB DURING PERCUTANEOUS CORONARY INTERVENTIONREDUCES BOTH EX-VIVO PLATELET THROMBUS FORMATION AND FIBRIN DEPOSITION - IMPLICATIONS FOR A POTENTIAL ANTICOAGULANT EFFECT OF ABCIXIMAB
Authors: DANGAS G BADIMON JJ COLLER BS FALLON JT SHARMA SK HAYES RM MERAJ P AMBROSE JA MARMUR JD
Citation: G. Dangas et al., ADMINISTRATION OF ABCIXIMAB DURING PERCUTANEOUS CORONARY INTERVENTIONREDUCES BOTH EX-VIVO PLATELET THROMBUS FORMATION AND FIBRIN DEPOSITION - IMPLICATIONS FOR A POTENTIAL ANTICOAGULANT EFFECT OF ABCIXIMAB, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1342-1349
ACTIVATION OF PLATELETS IN PLATELET-RICH PLASMA BY ROTABLATION IS SPEED DEPENDENT AND CAN BE INHIBITED BY ABCIXIMAB (C7E3 FAB REOPRO(TM))
Authors: WILLIAMS MS COLLER BS VAANANEN HJ SCUDDER LE MARMUR JD
Citation: Ms. Williams et al., ACTIVATION OF PLATELETS IN PLATELET-RICH PLASMA BY ROTABLATION IS SPEED DEPENDENT AND CAN BE INHIBITED BY ABCIXIMAB (C7E3 FAB REOPRO(TM)), Journal of the American College of Cardiology, 31(2), 1998, pp. 237-237
FIBRINOGEN COATING DENSITY AFFECTS THE CONFORMATION OF IMMOBILIZED FIBRINOGEN - IMPLICATIONS FOR PLATELET-ADHESION AND SPREADING
Authors: MOSKOWITZ KA KUDRYK B COLLER BS
Citation: Ka. Moskowitz et al., FIBRINOGEN COATING DENSITY AFFECTS THE CONFORMATION OF IMMOBILIZED FIBRINOGEN - IMPLICATIONS FOR PLATELET-ADHESION AND SPREADING, Thrombosis and haemostasis, 79(4), 1998, pp. 824-831
ACTIVATION OF PLATELETS IN PLATELET-RICH PLASMA BY ROTABLATION IS SPEED-DEPENDENT AND CAN BE INHIBITED BY ABCIXIMAB (C7E3 FAB, REOPRO)
Authors: WILLIAMS MS COLLER BS VAANANEN HJ SCUDDER LE SHARMA SK MARMUR JD
Citation: Ms. Williams et al., ACTIVATION OF PLATELETS IN PLATELET-RICH PLASMA BY ROTABLATION IS SPEED-DEPENDENT AND CAN BE INHIBITED BY ABCIXIMAB (C7E3 FAB, REOPRO), Circulation, 98(8), 1998, pp. 742-748
MONITORING PLATELET GP IIB IIIA ANTAGONIST THERAPY/
Authors: COLLER BS
Citation: Bs. Coller, MONITORING PLATELET GP IIB IIIA ANTAGONIST THERAPY/, Circulation, 97(1), 1998, pp. 4-9
PRENATAL-DIAGNOSIS OF GLANZMANN THROMBASTHENIA USING THE POLYMORPHIC MARKERS BRCA1 AND THRA1 ON CHROMOSOME-17
Authors: FRENCH DL COLLER BS USHER S BERKOWITZ R ENG C SELIGSOHN U PERETZ H
Citation: Dl. French et al., PRENATAL-DIAGNOSIS OF GLANZMANN THROMBASTHENIA USING THE POLYMORPHIC MARKERS BRCA1 AND THRA1 ON CHROMOSOME-17, British Journal of Haematology, 102(2), 1998, pp. 582-587
GLYCOPROTEIN IIB LEU214PRO MUTATION PRODUCES GLANZMANN THROMBASTHENIAWITH BOTH QUANTITATIVE AND QUALITATIVE ABNORMALITIES IN GPIIB IIIA/
Authors: GRIMALDI CM CHEN FP WU CH WEISS HJ COLLER BS FRENCH DL
Citation: Cm. Grimaldi et al., GLYCOPROTEIN IIB LEU214PRO MUTATION PRODUCES GLANZMANN THROMBASTHENIAWITH BOTH QUANTITATIVE AND QUALITATIVE ABNORMALITIES IN GPIIB IIIA/, Blood, 91(5), 1998, pp. 1562-1571
HEMATOLOGICALLY IMPORTANT MUTATIONS - GLANZMANN THROMBASTHENIA
Authors: FRENCH DL COLLER BS
Citation: Dl. French et Bs. Coller, HEMATOLOGICALLY IMPORTANT MUTATIONS - GLANZMANN THROMBASTHENIA, Blood cells, molecules, & diseases, 23(3), 1997, pp. 39-51
ADDITION OF A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR TO HEPARIN PLUS ASPIRIN DECREASES EX-VIVO THROMBUS FORMATION AFTER PERCUTANEOUS CORONARY INTERVENTION/
Authors: DANGAS G BADIMON JJ AMBROSE JA COLLER BS FALLON JT COHEN AM MERAJ P HAYES R SHARMA SK MARMUR JD
Citation: G. Dangas et al., ADDITION OF A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR TO HEPARIN PLUS ASPIRIN DECREASES EX-VIVO THROMBUS FORMATION AFTER PERCUTANEOUS CORONARY INTERVENTION/, Journal of the American College of Cardiology, 29(2), 1997, pp. 97483-97483
2 UNRELATED DOUBLY HETEROZYGOUS PATIENTS WITH GLANZMANN THROMBASTHENIA HAVE THE SAME GPIIA MUTATION RESULTING IN LOSS OF THE TRANSMEMBRANE DOMAIN
Authors: FRENCH DL CHEN FP XU L WEISS HJ COLLER BS
Citation: Dl. French et al., 2 UNRELATED DOUBLY HETEROZYGOUS PATIENTS WITH GLANZMANN THROMBASTHENIA HAVE THE SAME GPIIA MUTATION RESULTING IN LOSS OF THE TRANSMEMBRANE DOMAIN, Thrombosis and haemostasis, 1997, pp. 1475-1475
GENERATION OF PLATELET PROCOAGULANT ACTIVITY IN CLOTTING PLASMA, ROLEOF FIBRIN AND GPIIB IIIA RECEPTORS/
Authors: KUMAR R BEGUIN S KEULARTS I COLLER BS SELIGSOHN U HEMKER HC
Citation: R. Kumar et al., GENERATION OF PLATELET PROCOAGULANT ACTIVITY IN CLOTTING PLASMA, ROLEOF FIBRIN AND GPIIB IIIA RECEPTORS/, Thrombosis and haemostasis, 1997, pp. 2395-2395
THE GPIIIA CYS374-CYS386 DISULFIDE LOOP FORMS PART OF THE EPITOPE RECOGNIZED BY A MONOCLONAL-ANTIBODY THAT INHIBITS PLATELET-FUNCTION
Authors: GRIMALDI CM COLLER BS FRENCH DL
Citation: Cm. Grimaldi et al., THE GPIIIA CYS374-CYS386 DISULFIDE LOOP FORMS PART OF THE EPITOPE RECOGNIZED BY A MONOCLONAL-ANTIBODY THAT INHIBITS PLATELET-FUNCTION, Thrombosis and haemostasis, 1997, pp. 2749-2749
GPIIB IIIA ANTAGONISTS - PATHOPHYSIOLOGIC AND THERAPEUTIC INSIGHTS FROM STUDIES OF C7E3 FAB/
Authors: COLLER BS
Citation: Bs. Coller, GPIIB IIIA ANTAGONISTS - PATHOPHYSIOLOGIC AND THERAPEUTIC INSIGHTS FROM STUDIES OF C7E3 FAB/, Thrombosis and haemostasis, 78(1), 1997, pp. 730-735
PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/
Authors: COLLER BS
Citation: Bs. Coller, PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/, The Journal of clinical investigation, 99(7), 1997, pp. 1467-1471
PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/
Authors: COLLER BS
Citation: Bs. Coller, PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/, The Journal of clinical investigation, 100(11), 1997, pp. 57-60
MONITORING PLATELET GP IIA IIIB ANTAGONIST THERAPY/
Authors: COLLER BS
Citation: Bs. Coller, MONITORING PLATELET GP IIA IIIB ANTAGONIST THERAPY/, Circulation, 96(11), 1997, pp. 3828-3832
IN-VITRO EFFECTS OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS C7E3 FAB ON THE ACTIVATED CLOTTING TIME - RESPONSE/
Authors: AMAR T COLLER BS
Citation: T. Amar et Bs. Coller, IN-VITRO EFFECTS OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS C7E3 FAB ON THE ACTIVATED CLOTTING TIME - RESPONSE/, Circulation, 96(10), 1997, pp. 3794-3794
RAPID AND SIMPLE PLATELET-FUNCTION ASSAY TO ASSESS GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE/
Authors: COLLER BS LANG D SCUDDER LE
Citation: Bs. Coller et al., RAPID AND SIMPLE PLATELET-FUNCTION ASSAY TO ASSESS GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE/, Circulation, 95(4), 1997, pp. 860-867
IN-VITRO EFFECTS OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST C7E3 FAB ON THE ACTIVATED CLOTTING TIME/
Authors: AMMAR T SCUDDER LE COLLER BS
Citation: T. Ammar et al., IN-VITRO EFFECTS OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST C7E3 FAB ON THE ACTIVATED CLOTTING TIME/, Circulation, 95(3), 1997, pp. 614-617
THE RAPID PLATELET-FUNCTION ASSAY - A QUANTITATIVE METHOD FOR POINT OF CARE PLATELET MONITORING
Authors: SMITH JW LEE T COLEMAN J RATNIKOV B LY Y CARETTE S FERNANDEZ D FRELINGER L COLLER BS HILLMAN RS
Citation: Jw. Smith et al., THE RAPID PLATELET-FUNCTION ASSAY - A QUANTITATIVE METHOD FOR POINT OF CARE PLATELET MONITORING, Blood, 90(10), 1997, pp. 3028-3028
A GPIIB LEU214PRO MUTATION IDENTIFIED IN A PATIENT WITH GLANZMANN THROMBASTHENIA RESULTS IN BOTH QUANTITATIVE AND QUALITATIVE DEFECTS IN THE PLATELET GPIIB IIIA RECEPTOR/
Authors: FRENCH DL COLLER BS GRIMALDI CM
Citation: Dl. French et al., A GPIIB LEU214PRO MUTATION IDENTIFIED IN A PATIENT WITH GLANZMANN THROMBASTHENIA RESULTS IN BOTH QUANTITATIVE AND QUALITATIVE DEFECTS IN THE PLATELET GPIIB IIIA RECEPTOR/, Blood, 90(10), 1997, pp. 96-96
2 FORMS OF GPIIB-IIIA WITH DISTINCT CYTOPLASMIC TAILS AND LIGAND-BINDING PROPERTIES
Authors: HU DD WHITE CA JONGEWAARD IN SMITH JW COLLER BS
Citation: Dd. Hu et al., 2 FORMS OF GPIIB-IIIA WITH DISTINCT CYTOPLASMIC TAILS AND LIGAND-BINDING PROPERTIES, Blood, 90(10), 1997, pp. 2548-2548
BETA(3) INTEGRIN KNOCKOUT MICE DISPLAY A GLANZMANN THROMBASTHENIA PHENOTYPE
Authors: HODIVALADILKE KM MCHUGH K TSAKIRIS DA RAYBURN H ROSS FP COLLER BS TEITELBAUM S HYNES RO
Citation: Km. Hodivaladilke et al., BETA(3) INTEGRIN KNOCKOUT MICE DISPLAY A GLANZMANN THROMBASTHENIA PHENOTYPE, Blood, 90(10), 1997, pp. 2550-2550
7E3 F(AB')(2), A MONOCLONAL-ANTIBODY TO THE PLATELET GPIIB IIIA RECEPTOR, PROTECTS AGAINST MICROANGIOPATHIC HEMOLYTIC-ANEMIA AND MICROVASCULAR THROMBOTIC RENAL-FAILURE IN BABOONS TREATED WITH C4B BINDING-PROTEIN AND A SUBLETHAL INFUSION OF ESCHERICHIA-COLI/
Authors: TAYLOR FB COLLER BS CHANG ACK PEER G JORDAN R ENGELLENER W ESMON CT
Citation: Fb. Taylor et al., 7E3 F(AB')(2), A MONOCLONAL-ANTIBODY TO THE PLATELET GPIIB IIIA RECEPTOR, PROTECTS AGAINST MICROANGIOPATHIC HEMOLYTIC-ANEMIA AND MICROVASCULAR THROMBOTIC RENAL-FAILURE IN BABOONS TREATED WITH C4B BINDING-PROTEIN AND A SUBLETHAL INFUSION OF ESCHERICHIA-COLI/, Blood, 89(11), 1997, pp. 4078-4084
EFFECTS OF GPIIB IIIA INHIBITION ON PLATELET-RICH, FIBRIN-RICH, AND TOTAL EX-VIVO THROMBUS FORMATION UNDER DYNAMIC FLOW CONDITIONS/
Authors: DANGAS G BADIMON JJ COLLER BS FALLON JT SHARMA SK MERAJ P AMBROSE JA MARMUR JD
Citation: G. Dangas et al., EFFECTS OF GPIIB IIIA INHIBITION ON PLATELET-RICH, FIBRIN-RICH, AND TOTAL EX-VIVO THROMBUS FORMATION UNDER DYNAMIC FLOW CONDITIONS/, The American journal of cardiology, 80, 1997, pp. 86-86
Risultati: 1-25 | 26-50 | 51-75